Introduction
Fractional flow reserve (FFR) is the gold standard for guiding coronary revascularization in stable coronary artery disease (CAD). 1 The integration of quantitative anatomic and physiological modelling and computational fluid dynamics now enables non-invasive quantification of FFR from standard acquired coronary computed tomography angiography (CTA) datasets (FFR CT ). 2, 3 In large-scale prospective trials that included patients with known or suspected CAD, FFR CT showed high diagnostic performance when compared with invasively measured FFR. [4] [5] [6] Recent studies have demonstrated that the integration of coronary CTA with FFR CT in the diagnostic workup of patients is associated with a safe reduction of invasive coronary angiographies (ICAs), and in particular, in the number of patients with ICA failing to demonstrate obstructive lesions, and costs when compared with standard practice. 7, 8 Moreover, real-world feasibility of FFR CT in real-world practice has been demonstrated. 9 Microvascular impairment is prevalent in diabetes (DM) and hypertension (HTN), it occurs early, and is independent of the presence of atherosclerosis in the epicardial arteries. 10 In both conditions, the microvascular structure is abnormal and such patients demonstrate impaired endothelial function 11 and coronary flow reserve (CFR). 12 Although the clinical value of FFR seems independent of the presence of DM and HTN, the diagnostic performance of FFR CT in this setting is unknown. One of the core principles in the computation of FFR CT is that the hyperaemic response to adenosine is assumed to be predictable. This response depends on the structure and function of the microcirculation, thus it may be speculated that in hypertensive and diabetic patients, where left ventricular hypertrophy and microvascular impairment are more prevalent, the diagnostic performance of FFR CT is impaired. Therefore, the purpose of this study was to assess the diagnostic performance of FFR CT in hypertensive and diabetic patients using FFR as the reference standard.
Methods

Study population
This is a substudy of stable patients with suspected CAD and no prior coronary intervention from the 'Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography' (DeFACTO) and 'Analysis of Coronary Blood Flow Using CT Angiography: Next Steps' (NXT) trials. 5, 6 The study design of the prospective multicentre DeFACTO and NXT trials has been presented in detail previously. 13, 14 In the most recent NXT trial, adherence to societal guidelines on best CT acquisition practice 15 was mandated and CT image quality was assessed using a predefined scoring system for selection of appropriate cases for FFR CT analysis. This study includes the total NXT trial cohort (254 patients and 484 vessels) together with all patients (113 patients and 186 vessels) from the DeFACTO study that had adhered to the CT acquisition practice guidelines (e.g. sublingual nitroglycerin administration) and passed the same CT image quality scoring algorithm used for the NXT trial. 13 Thus, the total study cohort comprises 367 patients and 670 vessels. All FFR CT analyses were performed with the latestgeneration FFR CT analysis software (v1.4). 6 Refinements in the updated FFR CT analysis software included improved quantitative image quality analysis, improved image segmentation, refined physiological models, and increased automation. For the purpose of this study, CT scans from the DeFACTO study were reprocessed with the v1.4 FFR CT analysis software in a blinded fashion. In the DeFACTO trial, serious procedural complications occurred in three patients (coronary dissection, n ¼ 2; retroperitoneal hematoma, n ¼ 1) and in three patients in the NXT trial (coronary dissection, n ¼ 1; transient ischemic attack, n ¼ 2). 5, 6 Both trials included patients with known or suspected CAD with no exclusions of patients with left main disease, multivessel disease, serial lesions, bifurcation lesions, or vessel calcification. The main exclusion criteria in both trials were prior coronary intervention, bypass surgery, contraindications to beta-blockers, nitroglycerin or adenosine, recent myocardial infarction, or suspected acute coronary syndrome. A diagnosis of HTN and/or DM status was assigned to all patients at study inclusion based upon their self-reported medical history.
Coronary CTA acquisition and FFR CT computation
Coronary CTA was conducted by using single-or dual-source CT with a minimum of 64 detector rows as described previously. 5, 6 Oral and/or intravenous beta-blockers were administered to achieve a heart rate <60 beats/min and sublingual nitrates were given to ensure vasodilatation. Left ventricular mass (LVM) was derived from coronary CTA images as previously described. 16 In the DeFACTO trial, median (inter-quartile range) radiation dose was 6.4 (4.4-15.0) mSv, and in the NXT trial the mean (SD) radiation dose was 3.0 (2.2) mSv for prospective scans (n ¼ 138) and 14.3 (7.0) mSv for retrospective scans (n ¼ 116). 5, 6 FFR CT computation was conducted at HeartFlow (HeartFlow Inc., Redwood City, CA, USA) by independent blinded observers as previously described. 5, 6 In brief, for each patient a quantitative 3D model of the aortic root and epicardial arteries was generated from the coronary CTA images. Early diastolic phase (75%) was consistently chosen in all patients for image analysis. Integration of patient-specific mathematical models of coronary physiology to 3D computational fluid models enables computation of coronary flow and pressure at each point in the coronary tree under simulated hyperaemic conditions. FFR CT was calculated from the ratio of coronary pressure to aortic pressure. FFR CT 0.80 was regarded as indicative of ischaemia.
ICA and FFR-measurement
Invasive coronary angiography was conducted according to standard practice. 17 The FFR procedure has been described previously. 13 Briefly, FFR was measured under adenosine-induced hyperaemia (PressureWire, St. Jude Medical, St. Paul. MN; ComboWire Volcano Corp., San Diego, CA, USA) in at least one vessel with a stenosis at ICA >30%. Intravenous adenosine (140-180 lg/min/kg) was administered and after achieving steady state, the pressure distal to the stenosis was measured. FFR was defined as the ratio between the distal pressure to the aortic pressure during maximal hyperaemia. Only a drift of <0.05 was accepted. In the DeFACTO trial, FFR was read on-site by persons blinded to the CT and FFR CT results, whereas in the NXT trial FFR tracings were blindly interpreted at a core-lab (Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH, USA). Quantitative coronary angiography was conducted at independent core laboratories.
Data analysis and statistics
Continuous variables are presented as mean 6 SD and 95% CI as appropriate. Categorical variables are presented as numbers and percentages. The association between FFR CT and FFR assessed by Pearson's correlation coefficient, Bland-Altman plots, with 95% limits of agreement, and indices of diagnostic performance, respectively. One-way analysis of variance with Bonferroni post hoc test was used to evaluate intergroup differences. Per-patient and per-vessel discrimination of lesion-specific ischaemia by FFR CT was assessed by the area under the receiveroperating characteristic curve (ROC and AUC) with 95% CI in hypertensive, diabetic and control patients (no DM and no HTN) using FFR 0.80 as the reference standard. Per-patient and per-vessel FFR CT discrimination of ischaemia was assessed across left ventricular mass index (LVMI, left ventricular mass/body surface area) tertiles. We divided to LVMI-data into tertiles rather than quartiles or median in order to achieve an appropriate number of patients in each subgroup. AUC comparisons were performed according to the method previously described by DeLong et al. 
Results
Patients
Demographic characteristics of patients are shown in Table 1 . Mean (range) age was 63 (32-86) years and the majority of patients was of male gender (62%). HTN was present in 51%, DM in 4%, and 16% had both HTN and DM; controls without DM or HTN comprised 29% of the cohort. FFR CT and FFR were 0.80 in 48% and 38% of the patients, and 34% and 25% of the vessels, respectively ( Table 2) . Systolic blood pressure in the first LVMI tertile was lower compared with the second and third LVMI tertiles. Other demographic variables according to the presence of HTN and/or DM and LVM tertiles, respectively, are shown in Tables 3 and 4 . A representative case FFR CT assessment in a patient with HTN is shown in Figure 1 .
FFR CT diagnostic performance according to HTN and DM status
Per-patient sensitivity and NPV (95% CI) were higher in the HTN þ DM than in the control group, 90.5% (69. Table  8) . The per-patient and per-vessel AUC were comparable across LVMI tertiles ( Figure 3A and B).
Correlation of FFR CT to FFR
Bland-Altman plots revealed a difference between FFR and FFR CT of 0.031 in hypertensive, 0.047 in diabetic, 0.043 in HTN þ DM, and 0.040 in control vessels ( Figure 4 ). There were moderate correlations between FFR CT and FFR in vessels from patients with HTN (r 2 ¼ 0.56, P < 0.0001), DM (r 2 ¼ 0.66, P < 0.0001), HTN þ DM (r 2 ¼ 0.66, P < 0.0001), and controls (r 2 ¼ 0.51, P < 0.0001) ( Figure 5 ).
FFR-FFR CT correlation and Bland-Altman plots across LVMI tertiles are shown in Figure 6 . There was a trend towards increasing bias in the highest LVMI tertile.
Discussion
In this study, we demonstrated that the diagnostic performance and discrimination of ischaemia by FFR CT are independent of the presence of DM and HTN. Moreover, there was no difference in FFR CT discrimination of ischaemia across LVMI tertiles. However, there was a decline in both per-patient and -vessel diagnostic specificity of Values are given as mean 6 SD. One-way analysis of variance with Bonferroni's post hoc test. DBP, diastolic blood pressure; SBP, systolic blood pressure. *P < 0.05 and **P < 0.01 vs. LVMI tertile 3. The hallmark of HTN is increased total peripheral vascular resistance and preserved cardiac output. 19 The microcirculation plays a key role in the pathophysiology of HTN and in maintaining the high blood pressure. The small arteries undergo eutrophic remodelling, i.e. increased wall to lumen ratio and narrower vessel diameter by rearrangement of the smooth muscle cells. 10 impaired myogenic response causes hypertrophic vessel remodelling. 20 In both conditions, a decreased CFR characterizes the coronary microcirculatory impairment. 21 Although the basal coronary flow is increased, partly due to increased metabolic demand, the maximum hyperaemic flow during adenosine infusion is reduced. 22 Moreover, in the presence of CAD, CFR may also be impaired due to decreased myocardial capillary density. 23 The diagnostic performance of FFR in diabetic patients is high, although poor glycaemic control may impair the diagnostic specificity of FFR. 24 Adjusted for lumen diameter FFR is unaltered in diabetic microvascular changes in DM and HTN are reversible by selective vasodilator therapy. 10 In the current population, blood pressure was well controlled, and thus the microvascular changes induced by HTN and DM may to some extent have been reversed leaving the maximum hyperaemic response unaltered. This is supported by a previous study demonstrating unaltered coronary microvascular function in well-treated DM and HTN. 28 One of the underlying assumptions of the FFR CT -model is the predictability of the hyperaemic response. Previous studies have demonstrated an equal hyperaemic transit time of coronary flow across the normal thresholds for CFR and FFR in CAD. 29 Accordingly, the main reason for the decrease of CFR is the increase in baseline flow (which can be computed from the CTA images), and to a lesser extent a decrease in maximal coronary flow. Another underlying principle of the FFR CT model is that baseline coronary flow is proportional to left ventricular mass. 2 Thus, there is an increase in coronary artery size in patients with hypertrophic and dilated cardiomyopathies and aortic valve stenosis due to the larger left ventricular mass and increased flow demand. 30 This upshift in baseline myocardial perfusion and form-function relationship between left ventricular mass and vessel size increases baseline epicardial flow. Hence, myocardial blood flow is proportional to myocardial mass. 2 Accordingly, we found that the overall discrimination of ischaemia by FFR CT was unaltered across LVMI tertiles. However, there was a decline in FFR CT specificity of FFR CT in the highest LVMI tertile when compared with the lower tertile groups. Moreover, there was a tendency towards more FFR CT -FFR bias with increasing LVMI. Of note, patients in the highest LVMI tertile had significantly higher Agatston scores than lower tertile patients. It may be speculated that higher coronary calcification burden in patients with the highest LVMI may have influenced the diagnostic performance of FFR CT . In a recent substudy from the NXT trial, the diagnostic performance of FFR CT was shown to be high across Agatston quartiles. 29 However, although, not of statistical significance there was a tendency towards lower specificity on both a per-patient and a per-vessel basis in those patients with the highest Agatston scores. The influence of left ventricular hypertrophy and severe coronary calcification on the diagnostic performance of FFR CT needs further delineation in future studies. Taken together, and in accordance with previous findings demonstrating a high diagnostic performance of FFR CT independent of gender and age, 31 the findings in this study suggest that FFR CT remains a robust tool for ischaemia detection over a broad range of patients with stable CAD, even when DM, HTN, or both are present.
Study limitations
This is a substudy of previously reported prospective trials; hence, the results in this article are hypothesis generating. Microvascular impairment was extrapolated from the presence of HTN and DM. This is a valid notion, given the high prevalence and early presence of microvascular disease in HTN 32, 33 and DM. 28 However, microvascular resistance was not measured directly; hence, our conclusions relate to patients with HTN and/or DM. Although the impairment of microvascular resistance is ubiquitous, epicardial stenosis has a heterogeneous impact on resistance. 34 Thus, further studies are needed integrating pressure and flow measurements. Data on concomitant medical therapy were not available, and HTN and DM were classified according to medical history. Moreover, the number of patients with DM alone was small. Further studies are needed to address the specific association between the diagnostic performance of FFR CT and microvascular structure. We did not asses FFR CT in relation to CFR, which would provide incremental information on the microcirculation.
Conclusion
The diagnostic performance of FFR CT is independent of the presence of HTN and DM. FFR CT is a robust method in a broad population of patients with stable CAD, including patients at high risk for microvascular disease. Further studies with more precise delineation of microvascular dysfunction and overt left ventricular hypertrophy are needed to fully evaluate the diagnostic performance of FFR CT and FFR.
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